Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters









Database
Language
Publication year range
1.
Tenecteplase: a promising new fibrinolytic agent.
De Jong, M J; Sabadie-Garretson, W.
Dimens Crit Care Nurs ; 20(6): 19-23, 2001.
Article in English | MEDLINE | ID: mdl-22076580

ABSTRACT

Acute coronary syndrome can mean anything from unstable angina to acute myocardial infarction (MI) with ST-segment elevation. Tenecteplase, a new fibrinolytic agent used to treat ST-segment elevation acute MI, has some advantages over other fibrinolytic agents. This article describes tenecteplase's actions, indications, contraindications, and use.


Subject(s)
Acute Coronary Syndrome/drug therapy , Fibrinolytic Agents/therapeutic use , Tissue Plasminogen Activator/therapeutic use , Acute Coronary Syndrome/nursing , Drug Monitoring , Fibrinolytic Agents/administration & dosage , Fibrinolytic Agents/adverse effects , Humans , Male , Middle Aged , Tenecteplase , Tissue Plasminogen Activator/administration & dosage , Tissue Plasminogen Activator/adverse effects
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL